International Journal of Antimicrobial Agents
Volume 23, Issue 6 , Pages 577-581, June 2004

Prevalence of mupirocin resistance in clinical isolates of Staphylococcus aureus and Staphylococcus epidermidis: results of the Antimicrobial Resistance Surveillance Study of the Paul-Ehrlich-Society for Chemotherapy, 2001☆

  • Michael Kresken

      Affiliations

    • Antiinfectives Intelligence GmbH, Immenburgstraße 20, 53121 Bonn, Germany
    • Corresponding Author InformationCorresponding author. Tel.: +49-228-444-7060; fax: +49-228-444-70616.
    • ,
  • Dieter Hafner

      Affiliations

    • Institut für Pharmakologie und klinische Pharmakologie, Heinrich-Heine-Universität, Moorenstraße 5, 40225 Düsseldorf, Germany
    • Tel.: +49-211-811-2449; fax: +49-211-811-4781.
    • ,
  • Franz-Josef Schmitz

      Affiliations

    • Institut für Laboratoriumsmedizin, Mikrobiologie, Hygiene und Transfusionsmedizin, Kliniken im Mühlenkreis, Klinikum Minden, Friedrichstraße 17, 32427 Minden, Germany
    • Tel.: +49-571-801-3031; fax: +49-571-801-3034.
    • ,
  • Thomas A Wichelhaus

      Affiliations

    • Institut für Medizinische Mikrobiologie, Klinikum der Johann-Wolfgang-Goethe-Universität, Paul-Ehrlich-Straße 40, 60596 Frankfurt/Main, Germany
    • Tel.: +49-69-6301-6438; fax: +49-69-6301-5767.
    • ,
  • on behalf of the Working Group for Antimicrobial Resistance of the Paul-Ehrlich-Society for Chemotherapy

Received 10 October 2003; accepted 28 November 2003.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

☆ The Paul-Ehrlich-Society for Chemotherapy (Paul-Ehrlich-Gesellschaft für Chemotherapie) is a member of ISC.

PII: S0924-8579(04)00094-9

doi:10.1016/j.ijantimicag.2003.11.007

International Journal of Antimicrobial Agents
Volume 23, Issue 6 , Pages 577-581, June 2004

Article Tools